||**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024|**Trustees' Annual Report for the period**
Period start date
**To**
Period end date
1st
January 2024
31st
Decembe
r
2024| |---|---|---|---|---|---|---|---| ||**Trustees' Annual Report for the period**||||||| |**From**|Period start date|||**To**|Period end date||| ||1st|January|2024||31st|Decembe
r|2024| |Reference and administration details|||||||| ## **Charity name Clinical Genetics Society** ## **Other names charity is known by** CGS **Registered charity number (if any)** ## **Charity's principal address** |c/o Britsh Societyof Genetc Medicine|c/o Britsh Societyof Genetc Medicine| |---|---| |1 Naoroji Street
Islington|| |LONDON|| |**Postcode**|WC1X 0GB| **Names of the charity trustees who manage the charity** ||**Trustee name**|**Office (if any)**|**Dates acted if not for**
**whole year**|**Name of person**
**(or body)**
**entitled to**
**appoint trustee**
**(ifany)**| |---|---|---|---|---| |1.|Dr Mohnish Suri|President||| |2.|Professor Diana Baralle|Outgoing President||| |3.|Dr Meena
Balasubramanium|Academic Secretary||| |4.|Dr Sarah Bowdin|Secretary||| |5.|Dr Ian Ellis|Treasurer|From 1stJanuary2025|| |6.||||| |7.||||| |8.||||| |9.||||| |10.||||| |11.||||| |12.||||| **TAR** 1 May 2016 **Names of the trustees for the charity, if any, (for example, any custodian trustees)** |**Names of the trustees for the charity, if**|**any, (for example, any custodian trustees)**| |---|---| |**Name**|**Dates acted if not for whole year**| |Dr Emma Wakeling|1stJanuary 2024 - 31stDecember 2024,l and then
stood down| ||| ||| ## **Names and addresses of advisers (Optional information)** |**Type of adviser**|**Name**
**Address**|**Name**
**Address**| |---|---|---| |Fellow Association of
Charity Independent
Examiners|Rev'd. Alan A.
Clements|15 Carleton Road, Great Knowley, Chorley PR6 8TQ| |||| |||| |||| ## **Name of chief executive or names of senior staff members (Optional information)** ## **Section B Structure, governance and management Description of the charity’s trusts** Type of governing document Constitution (eg. trust deed, constitution) How the charity is constituted Association (eg. trust, association, company) Trustee selection methods By selection / election (eg. appointed by, elected by) **TAR** 2 May 2016 **Additional governance issues (Optional information)** You **may choose** to include additional information, where relevant, about: Call for members to apply to a Trustee post, selection by exiting Trustees and voting by member election if required - policies and procedures adopted for the induction and training of trustees; - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; - trustees’ consideration of major risks and the system and procedures to manage them. ## **Section C Objectives and activities** |**Summary of the objects of**
**the charity set out in its**
**governing document**
**Summary of the main**
**activities undertaken for the**
**public benefit in relation to**
**these objects (include within**
**this section the statutory**
**declaration that trustees**
**have had regard to the**
**guidance issued by the**
**Charity Commission on**
**public benefit)**|To advance and promote the science and medical practce
of Clinical Genetcs. For this purpose only it will bring
together persons who have a common interest in Clinical
Genetcs, so that they may be aided in their joint
endeavours to diagnose, understand, prevent, alleviate
and cure congenital malformatons and conditons with a
genetc aetology. In furtherance of these aims, but not
~~otherwise the Society may publish and disseminate~~|| |---|---|---| ||~~,~~
reports,statements,and research fndings.
Holding conferences and educational meetings.|| **TAR** 3 May 2016 Additonal details of objectves and actvites (Optonal informaton) You may choose to include further statements, where relevant, about: - policy on grantmaking; **TAR** May 2016 4 Section D Achievements and performance > Summary of the main Holding of a joint educational and scientific meeting, in > achievements of the collaboration with the Cancer Genetics Group (CGG). charity during the year Representing the interests of its members in national, health service and related governmental working parties on policies related to Clinical Genetics. Publishingh a report surveying the training pathway and career interests of Registrars and Academic Fellows training in Clinical Genetics. **TAR** May 2016 5 **Section E Financial review** We currently have a bank balance in excess of £90,000 and **Brief statement of the** feel that we need a working reserve of over £60,000 to **charity’s policy on reserves** protect the interests of the society. **Details of any funds materially in deficit** We are currently looking at a number of projects that will help us to invest these funds on behalf of the interests of **Further financial review** our members. **details (Optional information)** You **may choose** to include additional information, where relevant about: - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. ## **Section F Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s)** **Full name(s)** Ian Harold ELLIS **TAR** 6 May 2016 **Position (eg Secretary, Chair, etc)** Treasurer **Date. 28[th] March 2025** **TAR** May 2016 7 |**Clinical Genetics Society**
|**Clinical Genetics Society**
|**Clinical Genetics Society**
|**274959**|**CC16a**
| |---|---|---|---|---| |**Receipts andpayments accounts**||||| |**For the period**
**from**|1st January 2024|**To**
|2024
31st December|| |**Section A Receipts and payments**|**Section A Receipts and payments**||||| |---|---|---|---|---|---| |**A1 Receipts**
**Section A Receipts and payments**
Subscriptions In from BSGM
**730**
Conefrence Registration Fees from BSGM
**62,570**
Conference Sponsors
**8,866**
Other Income
**765**
Payment byBSGM
**8,440**
**81,371**
**Sub total**
**Total receipts 81,371**
**A3 Payments**
BankCharges
**278**
ReeltimeEvents
**1,956**
Travelawards & prizes
**1,327**
MedicalStudentEssayPrizeAccom. Expenses
**323**
Accommodation/ Subsitence
**4,677**
Room hire / catering/ organisation
**36,139**
Accom, subsistence, travel, registration
**4,677**
Payment to CancerGenetics Group
**30,122**
Conference Gifts /Extras
**1,243**
Admin&Running Costs paids toRSB
**17,004**
**Sub total 97,747**
**Unrestricted**
**funds**
**to the nearest £**
**Sub total**(Gross income for AR)
**A2 Asset and investment sales, (see**
**table).**||**to the nearest £**
**Restricted**
**funds**|**Endowmen**
**t funds**
**to the nearest**
**£**|**Total funds**
**Last year**
**to the nearest £**
**to the nearest**
**£**|| |||||**730**
**62,570**|| ||||||| |||||**8,866**|| |||||**765**|| |||||**8,440**|| ||||||| ||||||| ||||||| |||||**81,371**|**56,315**| ||||||| ||||||| ||||||| ||||||| ||||||| |||||**81,371**|**56,315**| ||||||| |
BankCharges|**278**|||**278**|| |ReeltimeEvents|**1,956**|||**1,956**|| |Travelawards & prizes|**1,327**|||**1,327**|| |MedicalStudentEssayPrizeAccom. Expenses|**323**|||**323**|| |Accommodation/ Subsitence|**4,677**|||**4,677**|| |Room hire / catering/ organisation|**36,139**|||**36,139**|| |Accom, subsistence, travel, registration|**4,677**|||**4,677**|| |Payment to CancerGenetics Group|**30,122**|||**30,122**|| |Conference Gifts /Extras|**1,243**|||**1,243**|| |Admin&Running Costs paids toRSB|**17,004**|||**17,004**|| |**Sub total **|**97,747**|||**97,747**|**24,071**| |**A4 Asset and investment purchases,**||||||||||| |---|---|---|---|---|---|---|---|---|---|---| |**(see table)**||||||||||| |||||||||||| |||||||||||| |**Sub total **||**97,747**||||||**97,747**|**24,071**|| |||||||||||| |**Total payments **||**97,747**||||||**97,747**|**24,071**|| |||||||||||| |**Net of receipts/(payments) -**||**16,376**||||||**- 16,376**|**32,244**|| |**A5 Transfers between funds**||||||||||| |**A6 Cash funds last year end**||**97,887**||||||**97,887**|**65,643**|| |**Cash funds this year end **||**81,511**||||||**81,511**|**97,887**|| ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B3 Investment assets**
**B5 Liabilities**
**B4 Assets retained for the charity’s**
**own use**
Signed by one or two trustees on behalf of all
the trustees|**Details**
Bank
**Details**
**Details**
**Details**
**Details**
Signature
**Total cash funds**
(agree balances with receipts and payments
account(s))|**to nearest £**
**81,511**
**81,511**
OK
**to nearest £**
**Unrestricte**
**d funds**
**Unrestricte**
**d funds**
**Fund to which**
**asset belongs**
**Fund to which**
**asset belongs**
**Fund to which**
**liability**
**relates**|**to nearest £**
**to nearest £**
**Restricted**
**funds**
**Endowment**
**funds**|**to nearest £**
**to nearest £**
**Restricted**
**funds**
**Endowment**
**funds**| |---|---|---|---|---| |||||| |||||| |||||| |||||| |||||| ||||**to nearest £**
**to nearest £**
**Restricted**
**funds**
**Endowment**
**funds**|| |||||| |||||| |||||| |||||| |||||| |||||| ||||**Cost**
**(optional)**
**Current value**
**(optional)**|| |||||| |||||| |||||| |||||| |||||| ||||**Cost**
**(optional)**
**Current value**
**(optional)**|| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ||||**Amount due**
**(optional)**
**When due**
**(optional)**|| |||||| |||||| |||||| |||||| |||||| |||||| |||Print Name
Date of
approval||| |||**Ian Ellis**||**28th March 2025**| |||||| CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examiner s Report Report to the trusteesl ClinKal GenelTh ScrEty On accounts for the year | 31*. Decwth 2024 Charity no lifany)'2 74 9&9 Sèt out on pages One and two I re[￿ to the trustees on 6xaTrnat￿M of the accounts ofthe above ch*ty Trusf) for the year ended 31*. De(xnber 2024. Re8pon8ibllities and basls of roport As the charty trustees of the Tfust. you are reSk￿￿$Ib￿ fof the preparation of the ac£ounts in accordan￿ wrth the requiremerts ofthe Charities Act 2011 fthe Acr) I rewt in respect of my examinatkn ofthe Tn￿8 wjunts camed out under Sect￿Tr 145 of the 2011 Acl and in carrying out frry examination, I have foll¢ywed the app1Kab￿ Directir￿S gi¥en by the Charty Commisslon under secth)n 14515Mbl of the Act. I have completed my exami￿. I confirm that no material matters have come to my attentson l in connection wrth the examinaon whth gN8s me cause to beI￿ve that In. ary material Independent examlneVs statement accounting records were nck kept in acoydance with 8ectK)n 130 of the Act or the accounts do not ￿)rd with the attounting r￿￿rdS I have no concwns and have come a(ms8 no olher matters in connecth)n wrth Ihe examinalM)n to wh￿h attention should be drawn in (￿der to enabEe a proper understanding ofthe &counts to be ￿8¢he￿. ' Ple8se delete the words in the br￿etS rflhey do nol appty. Signed: J14 2V. March 2025 R*d. Akn K c￿rnents Rtlwant wofessional qualificatlorfs) or body (if any): Associth of Charity Inknndent Exarniners Addrfr3$: 15 Carlth R(>ad, Great KTh*. Chorf8y PR6 8TQ IER October 2018